JuneBrain Inc. is at the forefront of advancing retinal imaging technology, specifically through its innovative optical coherence tomography (OCT) solutions. Their flagship product, the Neuro-i SS-OCT, is designed to be a user-friendly and portable device that enhances accessibility to retinal imaging in both clinical and point-of-care environments. This technology aims to facilitate remote assessments and monitoring of neurological and retinal diseases, thereby improving health outcomes for patients globally. The company's commitment to telehealth is evident in its development of AI software solutions that complement their imaging devices, making it easier for healthcare providers to analyze and interpret data efficiently.

In addition to their imaging devices, JuneBrain operates a specialized Reading Center that focuses on the automated and quantitative analysis of OCT data, particularly for neurological research. This integration of advanced imaging technology with AI-driven analytics positions JuneBrain as a leader in the field, enabling more accurate and timely diagnoses of eye and brain diseases. Their vision emphasizes expanding access to healthcare, which is crucial for improving patient outcomes in underserved populations. Overall, JuneBrain's innovative approach combines cutting-edge technology with a strong commitment to enhancing healthcare accessibility.

United States

JuneBrain is an early start-up company based in the Washington, DC area. Our mission is to develop a telehealth eye-scanning system that allows clinicians to monitor patients with eye and brain disease outside of the traditional clinical setting, leading to earlier detection of new disease and improved monitoring of treatment efficacy. 

Though our mission begins in the eye care community, our long-term goal is to extend the use of our device into the broader neurological disease population, thus creating a pathway towards more frequent, widely accessible monitoring of eye and brain health.

JuneBrain Inc.

Company Details